Chris Marohnic

Title: Chris Marohnic: Innovator in Anti-HCV Antibody Detection

Introduction

Chris Marohnic is a notable inventor based in Kenosha, Wisconsin. He has made significant contributions to the field of medical diagnostics, particularly in the detection of anti-HCV antibodies. His innovative work has led to the development of a patented method that enhances the accuracy and efficiency of HCV antibody detection.

Latest Patents

Chris Marohnic holds a patent for his invention titled "Anti-HCV Antibody Detection Assays Employing NS3 Capture Peptides." This patent provides methods, kits, and compositions for detecting subject anti-HCV antibodies in a sample using NS3 capture peptides. The invention employs at least two NS3 helicase (NS3h) capture peptides and at least two conjugate peptides, allowing for a broad dynamic range of antibody detection in a one-step assay. Additionally, the patent outlines methods for detecting NS3-specific subject antibodies without the use of a reducing agent, showcasing the versatility of his approach.

Career Highlights

Chris Marohnic is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions in diagnostics, contributing to advancements in the detection of viral infections.

Collaborations

Throughout his career, Chris has collaborated with talented individuals such as Anthony Scott Muerhoff and John C Prostko. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies in the field of medical diagnostics.

Conclusion

Chris Marohnic's contributions to the field of anti-HCV antibody detection exemplify the impact of innovation in healthcare. His patented methods not only enhance diagnostic capabilities but also pave the way for future advancements in medical technology.